Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Teprotumumab for the treatment of Thyroid eye disease.
Ugradar S, Malkhasyan E, Douglas RS. Ugradar S, et al. Among authors: douglas rs. Endocr Rev. 2024 Jun 5:bnae018. doi: 10.1210/endrev/bnae018. Online ahead of print. Endocr Rev. 2024. PMID: 38838219
Outcome measures for chronic rhinosinusitis with nasal polyps.
Sedaghat AR, Campbell RG, Douglas RG, Fokkens WJ, Hamizan AW, Korban ZR, Lee VS, Macias-Valle L, Romano FR, Snidvongs K, Alsaleh S. Sedaghat AR, et al. Among authors: douglas rg. Rhinology. 2024 Jun 3. doi: 10.4193/Rhin24.090. Online ahead of print. Rhinology. 2024. PMID: 38829175
Teprotumumab improves light sensitivity in patients with thyroid eye disease.
Parunakian E, Ugradar S, Tolentino J, Malkhasyan E, Raika P, Ghaly J, Bisht C, Douglas RS. Parunakian E, et al. Among authors: douglas rs. Graefes Arch Clin Exp Ophthalmol. 2024 Apr 19. doi: 10.1007/s00417-024-06491-0. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38639788
1,310 results